BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28560500)

  • 1. Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells.
    Lee JE; Kwon YJ; Baek HS; Ye DJ; Cho E; Choi HK; Oh KS; Chun YJ
    Arch Pharm Res; 2017 Jun; 40(6):746-759. PubMed ID: 28560500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with auranofin and trametinib induces synergistic apoptosis in breast cancer cells.
    Joo MK; Shin S; Ye DJ; An HG; Kwon TU; Baek HS; Kwon YJ; Chun YJ
    J Toxicol Environ Health A; 2021 Jan; 84(2):84-94. PubMed ID: 33103613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with auranofin and nutlin-3a induces synergistic cytotoxicity in breast cancer cells.
    Ye DJ; Kwon YJ; Baek HS; Cho E; Kwon TU; Chun YJ
    J Toxicol Environ Health A; 2019; 82(10):626-637. PubMed ID: 31258040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
    Zhao Y; Wang X; Sun Y; Zhou Y; Yin Y; Ding Y; Li Z; Guo Q; Lu N
    Apoptosis; 2015 Sep; 20(9):1253-69. PubMed ID: 26153346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.
    Liu C; Liu Z; Li M; Li X; Wong YS; Ngai SM; Zheng W; Zhang Y; Chen T
    PLoS One; 2013; 8(1):e53945. PubMed ID: 23342042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin promotes mitochondrial apoptosis by inducing annexin A5 expression and translocation in human prostate cancer cells.
    Park N; Chun YJ
    J Toxicol Environ Health A; 2014; 77(22-24):1467-76. PubMed ID: 25343295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
    Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Activity of an Antimetabolite Drug and Tyrosine Kinase Inhibitors against Breast Cancer Cells.
    Wu Y; Zhang D; Wu B; Quan Y; Liu D; Li Y; Zhang X
    Chem Pharm Bull (Tokyo); 2017 Aug; 65(8):768-775. PubMed ID: 28539531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
    Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
    Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auranofin inhibits the proliferation of lung cancer cells via necrosis and caspase‑dependent apoptosis.
    Cui XY; Park SH; Park WH
    Oncol Rep; 2020 Dec; 44(6):2715-2724. PubMed ID: 33125149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
    Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
    Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Inhibition of Breast Cancer Cell Growth by an Epigenome-Targeting Drug and a Tyrosine Kinase Inhibitor.
    Wu YS; Quan Y; Zhang DX; Liu DW; Zhang XZ
    Biol Pharm Bull; 2017; 40(10):1747-1753. PubMed ID: 28966246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis.
    Zhang N; Kong X; Yan S; Yuan C; Yang Q
    Cancer Sci; 2010 Nov; 101(11):2375-83. PubMed ID: 20718753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ω-hydroxyundec-9-enoic acid induction of breast cancer cells apoptosis through generation of mitochondrial ROS and phosphorylation of AMPK.
    Ahn J; Kim H; Yang KM
    Arch Pharm Res; 2020 Jul; 43(7):735-743. PubMed ID: 32720162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.
    Chen T; Wong YS
    Int J Biochem Cell Biol; 2009 Mar; 41(3):666-76. PubMed ID: 18718551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin induces apoptosis and necrosis in HeLa cells via oxidative stress and glutathione depletion.
    You BR; Shin HR; Han BR; Kim SH; Park WH
    Mol Med Rep; 2015 Feb; 11(2):1428-34. PubMed ID: 25370167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greensporone A, a Fungal Secondary Metabolite Suppressed Constitutively Activated AKT via ROS Generation and Induced Apoptosis in Leukemic Cell Lines.
    Prabhu KS; Siveen KS; Kuttikrishnan S; Jochebeth A; Ali TA; Elareer NR; Iskandarani A; Quaiyoom Khan A; Merhi M; Dermime S; El-Elimat T; Oberlies NH; Alali FQ; Steinhoff M; Uddin S
    Biomolecules; 2019 Mar; 9(4):. PubMed ID: 30934922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Cell Necroptosis and Apoptosis Induced by Shikonin via Receptor Interacting Protein Kinases in Estrogen Receptor Positive Breast Cancer Cell Line, MCF-7.
    Shahsavari Z; Karami-Tehrani F; Salami S
    Anticancer Agents Med Chem; 2018; 18(2):245-254. PubMed ID: 28933271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Induction of Apoptosis by the Combination of an Axl Inhibitor and Auranofin in Human Breast Cancer Cells.
    Ryu YS; Shin S; An HG; Kwon TU; Baek HS; Kwon YJ; Chun YJ
    Biomol Ther (Seoul); 2020 Sep; 28(5):473-481. PubMed ID: 32536618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menin‑MLL inhibitors induce ferroptosis and enhance the anti‑proliferative activity of auranofin in several types of cancer cells.
    Kato I; Kasukabe T; Kumakura S
    Int J Oncol; 2020 Oct; 57(4):1057-1071. PubMed ID: 32945449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.